UTAH MEDICAL PRODUCTS INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $38.5 | $40.9 | $50.2 | $52.3 | $49.1 |
| Operating income | $11.4 | $13.6 | $16.8 | $19.8 | $18.9 |
| Net income | $11.3 | $13.9 | $16.6 | $16.5 | $14.8 |
| Cash Flow Statement | |||||
| Free cash flow | $14.3 | $14.6 | $21.6 | $20.3 | $20.7 |
| Dividends | $4.0 | $4.3 | $4.3 | $3.2 | $11.5 |
| Share repurchases | $8.4 | $20.0 | $0.0 | $2.5 | $0.0 |
Shares outstanding 3.2M · Free float 92.0%
Annual filing data through FY ended December 31, 2025; float as of September 19, 2026.